EGFR and colon adenocarcinoma: For example, in colon adenocarcinoma, highly sensitive techniques and application of anti-EGFR therapy have made it possible to detect up to 70% of Ras mutations in blood in series where the percentage diagnosed in the primary tumor was approximately 40–45% based on standard molecular techniques [120].